← Back to overview

CRL Charles River Laboratories Inte

Life Sciences Tools & Services · $226.58 -1.18%
EN PL
Price Alert:

Compare

Shows % change over the period so different-priced stocks can be compared fairly.

Technical Indicators

RSI (14)
58.2
Relative Strength Index (RSI): measures how fast and how much the price has moved recently, on a 0-100 scale. Above 70 is often called "overbought" (may be due for a pause or pullback); below 30 is "oversold" (may be due for a bounce). It is not a guarantee either way.
SMA 20 / 50 / 200
176.14 / 197.86 / 133.31
Moving Averages (SMA): the average closing price over the last N days, smoothing out day-to-day noise. When price trades above its moving averages, and shorter averages are above longer ones, it is generally read as a healthier trend.
MACD / Signal
4.08 / -4.41
MACD: compares two moving averages (12-day and 26-day) to gauge momentum. When the MACD line crosses above its signal line, momentum is turning up; crossing below suggests momentum turning down.

Fundamentals

P/E
Price-to-Earnings ratio: how many dollars investors pay for $1 of the company's annual profit. Higher usually means the market expects faster growth (or the stock is expensive); lower can mean it's cheap — or that growth is expected to slow.
Market Cap
10.91B
Market Capitalization: the total value of all the company's shares — share price × number of shares. A rough measure of company size.
Div Yield
Dividend Yield: the annual cash dividend paid to shareholders, as a percentage of the current share price.
52-Week Range
144.26 – 238.85
52-Week Range: the lowest and highest price the stock has traded at over the last year. Where the price sits in this range hints at recent strength or weakness.

Trend Analysis

Charles River Laboratories Inte is trading at $226.58, -1.18% versus the previous close. The price is near its 52-week high — the top of its recent trading range.
RSI is in a neutral range — no strong overbought/oversold signal.
The 50-day average is above the 200-day average ("golden cross" territory) — a commonly watched bullish signal.
MACD is above its signal line — momentum currently leans positive.
Combine this reading with the fundamentals below before forming a view — no single indicator is a guarantee of what happens next.

Latest News

HCA Q2 Earnings Beat on Strong Admissions, 2026 Outlook Revised
Zacks · 2026-07-24 15:47
In Vitro Toxicology Testing Market to Exceed $20.97 Billion by 2031 as Non-Animal Testing & AI Adoption Accelerate - Analysis by Product, Toxicity Endpoints & Type, Technology, Method, Service, Region
GlobeNewswire · 2026-07-23 14:09
3 Profitable Stocks with Warning Signs
StockStory · 2026-07-23 08:20
3 Healthcare Stocks We Approach with Caution
StockStory · 2026-07-22 14:06
Charles River Laboratories Earnings Preview: What to Expect
Barchart · 2026-07-20 15:43
What Makes Charles River Laboratories (CRL) a Strong Momentum Stock: Buy Now?
Zacks · 2026-07-17 16:00
Charles River Laboratories International (CRL) Expands Cell Therapy Work, Is The Stock Still Undervalued?
Simply Wall St. · 2026-07-17 04:33
Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market
Zacks · 2026-07-16 15:50
Educational information only. Nothing here is investment advice — always do your own research and consider talking to a licensed financial advisor before buying or selling.
Data: Yahoo Finance, refreshed periodically and cached locally.